Table 1.

Anti-proliferative effects of CDDP and CAM administered separately in BC cell lines (MCF7, T47D, MDA-MB-231, and MDA-MB-468) measured in vitro by the MTT assay. n—total number of items used at concentrations whose expected anti-proliferative effects ranged between 4 and 6 probits (16 and 84%).

Cell Line	Drug	IC50 (μg/mL)	n
MCF7	CDDP	1.571 ± 0.373	72
MCF7	CAMBINOL	20.314 ± 1.176	72
T47D	CDDP	1.127 ± 0.384	90
T47D	CAMBINOL	16.512 ± 1.261	54
MDA-MB-231	CDDP	1.507 ± 0.536	90
MDA-MB-231	CAMBINOL	13.437 ± 1.287	72
MDA-MB-468	CDDP	1.571 ± 0.563	90
MDA-MB-468	CAMBINOL	15.028 ± 1.199	72